Detalhe da pesquisa
1.
Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.
Int J Cancer
; 148(8): 1928-1937, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152115